D. Pardoll, VACCINES: SPINNING MOLECULAR IMMUNOLOGY INTO SUCCESSFUL IMMUNOTHERAPY, Nature Reviews Immunology, vol.254, issue.4, pp.227-238, 2002.
DOI : 10.1073/pnas.96.6.2982

F. Nestle, J. Banchereau, and D. Hart, Dendritic cells: On the move from bench to bedside, Nature Medicine, vol.7, issue.7, pp.761-765, 2001.
DOI : 10.1038/89863

R. Steinman and M. Dhodapkar, Active immunization against cancer with dendritic cells: The near future, International Journal of Cancer, vol.94, issue.4, pp.459-473, 2001.
DOI : 10.1002/ijc.1503

M. Dhodapkar, R. Steinman, M. Sapp, H. Desai, C. Fossella et al., Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells, Journal of Clinical Investigation, vol.104, issue.2, pp.173-180, 1999.
DOI : 10.1172/JCI6909

B. Schuler-thurner, D. Dieckmann, P. Keikavoussi, A. Bender, C. Maczek et al., Mage-3 and Influenza-Matrix Peptide-Specific Cytotoxic T Cells Are Inducible in Terminal Stage HLA-A2.1+ Melanoma Patients by Mature Monocyte-Derived Dendritic Cells, The Journal of Immunology, vol.165, issue.6, pp.3492-3496, 2000.
DOI : 10.4049/jimmunol.165.6.3492

B. Schuler-thurner, E. Schultz, T. Berger, G. Weinlich, S. Ebner et al., Rapid Induction of Tumor-specific Type 1 T Helper Cells in Metastatic Melanoma Patients by Vaccination with Mature, Cryopreserved, Peptide-loaded Monocyte-derived Dendritic Cells, The Journal of Experimental Medicine, vol.160, issue.10, pp.1279-1288, 2002.
DOI : 10.1016/S0091-6749(98)70117-4

A. Palucka, M. Dhodapkar, S. Paczesny, S. Burkeholder, K. Wittkowski et al., Single Injection of CD34+ Progenitor-Derived Dendritic Cell Vaccine Can Lead to Induction of T-Cell Immunity in Patients With Stage IV Melanoma, Journal of Immunotherapy, vol.26, issue.5, pp.432-439, 2003.
DOI : 10.1097/00002371-200309000-00006

S. Paczesny, J. Banchereau, K. Wittkowski, G. Saracino, J. Fay et al., Progenitor-derived Dendritic Cells, The Journal of Experimental Medicine, vol.14, issue.11, pp.1503-1511, 2004.
DOI : 10.1146/annurev.immunol.17.1.19

J. Banchereau, A. Palucka, M. Dhodapkar, S. Burkeholder, N. Taquet et al., Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine, Cancer Res, vol.61, pp.6451-6458, 2001.

J. Banchereau, B. Schuler-thurner, A. Palucka, and G. Schuler, Dendritic Cells as Vectors for Therapy, Cell, vol.106, issue.3, pp.271-274, 2001.
DOI : 10.1016/S0092-8674(01)00448-2

Y. Ikarashi, R. Mikami, A. Bendelac, M. Terme, N. Chaput et al., Dendritic Cell Maturation Overrules H-2d???Mediated Natural Killer T (Nkt) Cell Inhibition, The Journal of Experimental Medicine, vol.162, issue.8, pp.1179-1186, 2001.
DOI : 10.1073/pnas.95.13.7556

M. Terme, E. Tomasello, K. Maruyama, F. Crepineau, N. Chaput et al., IL-4 Confers NK Stimulatory Capacity to Murine Dendritic Cells: A Signaling Pathway Involving KARAP/DAP12-Triggering Receptor Expressed on Myeloid Cell 2 Molecules, The Journal of Immunology, vol.172, issue.10, pp.5957-5966, 2004.
DOI : 10.4049/jimmunol.172.10.5957

P. Guermonprez, L. Saveanu, M. Kleijmeer, J. Davoust, P. Van-endert et al., ER???phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells, Nature, vol.425, issue.6956, pp.397-402, 2003.
DOI : 10.1038/nature01911

M. Kleijmeer, J. Escola, F. Uytdehaag, E. Jakobson, J. Griffith et al., Antigen Loading of MHC Class I Molecules in the Endocytic Tract, Traffic, vol.154, issue.2, pp.124-137, 2001.
DOI : 10.1038/343071a0

G. Raposo, H. Nijman, W. Stoorvogel, R. Liejendekker, C. Harding et al., B lymphocytes secrete antigen-presenting vesicles, Journal of Experimental Medicine, vol.183, issue.3, pp.1161-1172, 1996.
DOI : 10.1084/jem.183.3.1161

L. Zitvogel, A. Regnault, A. Lozier, J. Wolfers, C. Flament et al., Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell derived exosomes, Nature Medicine, vol.180, issue.5, pp.594-600, 1998.
DOI : 10.1073/pnas.94.7.3262

K. Denzer, M. Kleijmeer, H. Heijnen, W. Stoorvogel, and H. Geuze, Exosome: from internal vesicle of the multivesicular body to intercellular signaling device, J Cell Sci, vol.113, issue.19, pp.3365-3374, 2000.

J. Escola, M. Kleijmeer, W. Stoorvogel, J. Griffith, Y. O. Geuze et al., Selective Enrichment of Tetraspan Proteins on the Internal Vesicles of Multivesicular Endosomes and on Exosomes Secreted by Human B-lymphocytes, Journal of Biological Chemistry, vol.273, issue.32, pp.20121-20127, 1998.
DOI : 10.1074/jbc.273.32.20121

A. Clayton, J. Court, H. Navabi, M. Adams, M. Mason et al., Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry, Journal of Immunological Methods, vol.247, issue.1-2, pp.163-174, 2001.
DOI : 10.1016/S0022-1759(00)00321-5

F. Andre, N. Chaput, N. Schartz, C. Flament, A. N. Bernard et al., Exosomes as Potent Cell-Free Peptide-Based Vaccine. I. Dendritic Cell-Derived Exosomes Transfer Functional MHC Class I/Peptide Complexes to Dendritic Cells, The Journal of Immunology, vol.172, issue.4, pp.2126-2136, 2004.
DOI : 10.4049/jimmunol.172.4.2126

N. Chaput, N. Schartz, F. Andre, J. Taieb, S. Novault et al., Exosomes as Potent Cell-Free Peptide-Based Vaccine. II. Exosomes in CpG Adjuvants Efficiently Prime Naive Tc1 Lymphocytes Leading to Tumor Rejection, The Journal of Immunology, vol.172, issue.4, pp.2137-2146, 2004.
DOI : 10.4049/jimmunol.172.4.2137

D. Hsu, P. Paz, G. Villaflor, A. Rivas, A. Mehta-damani et al., Exosomes as a Tumor Vaccine: Enhancing Potency Through Direct Loading of Antigenic Peptides, Journal of Immunotherapy, vol.26, issue.5, pp.440-450, 2003.
DOI : 10.1097/00002371-200309000-00007

C. Thery, L. Duban, E. Segura, P. Veron, O. Lantz et al., Indirect activation of na??ve CD4+ T cells by dendritic cell???derived exosomes, Nature Immunology, vol.3, issue.12, pp.1156-1162, 2002.
DOI : 10.1038/ni854

C. Thery, M. Boussac, P. Veron, P. Ricciardi-castagnoli, G. Raposo et al., Proteomic Analysis of Dendritic Cell-Derived Exosomes: A Secreted Subcellular Compartment Distinct from Apoptotic Vesicles, The Journal of Immunology, vol.166, issue.12, pp.7309-7318, 2001.
DOI : 10.4049/jimmunol.166.12.7309

C. Thery, L. Zitvogel, and S. Amigorena, Exosomes: composition, biogenesis and function, Nat Rev Immunol, vol.2, pp.569-579, 2002.

H. Lamparski, A. Metha-damani, J. Yao, S. Patel, D. Hsu et al., Production and characterization of clinical grade exosomes derived from dendritic cells, Journal of Immunological Methods, vol.270, issue.2, pp.211-226, 2002.
DOI : 10.1016/S0022-1759(02)00330-7

P. Weynants, B. Lethe, F. Brasseur, M. Marchand, and T. Boon, Expression of mage genes by non-small-cell lung carcinomas, International Journal of Cancer, vol.256, issue.6, pp.826-829, 1994.
DOI : 10.1002/ijc.2910560612

D. Scarcella, C. Chow, M. Gonzales, C. Economou, F. Brasseur et al., Expression of MAGE and GAGE in high-grade brain tumors: a potential target for specific immunotherapy and diagnostic markers, Clin Cancer Res, vol.5, pp.335-341, 1999.

C. Scheibenbogen, K. Lee, S. Stevanovic, M. Witzens, M. Willhauck et al., Analysis of the T cell response to tumor and viral peptide antigens by an IFN??-ELISPOT assay, International Journal of Cancer, vol.17, issue.6, pp.932-936, 1997.
DOI : 10.1002/(SICI)1097-0215(19970611)71:6<932::AID-IJC3>3.0.CO;2-Z

P. Coulie, V. Karanikas, D. Colau, C. Lurquin, C. Landry et al., A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3, Proceedings of the National Academy of Sciences, vol.190, issue.5, pp.10290-10295, 2001.
DOI : 10.1084/jem.190.5.705

A. Michael, J. Morse, T. Osada, S. Khan, A. Hobeika et al., A Phase I Study of Dexosome Immunotherapy in Patients with Advanced Non-Small Cell Lung Cancer, J Transl Med, vol.3, p.9, 2005.

M. Marchand, N. Van-baren, P. Weynants, V. Brichard, B. Dreno et al., Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by geneMAGE-3 and presented by HLA-A1, International Journal of Cancer, vol.56, issue.2, pp.219-230, 1999.
DOI : 10.1002/(SICI)1097-0215(19990118)80:2<219::AID-IJC10>3.0.CO;2-S